BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 28415647)

  • 1. Contrast agents in dynamic contrast-enhanced magnetic resonance imaging.
    Yan Y; Sun X; Shen B
    Oncotarget; 2017 Jun; 8(26):43491-43505. PubMed ID: 28415647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic contrast-enhanced MRI for oncology drug development.
    Sung YS; Park B; Choi Y; Lim HS; Woo DC; Kim KW; Kim JK
    J Magn Reson Imaging; 2016 Aug; 44(2):251-64. PubMed ID: 26854494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MR imaging of tumor microcirculation: promise for the new millennium.
    Taylor JS; Tofts PS; Port R; Evelhoch JL; Knopp M; Reddick WE; Runge VM; Mayr N
    J Magn Reson Imaging; 1999 Dec; 10(6):903-7. PubMed ID: 10581502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic contrast-enhanced magnetic resonance imaging in oncology.
    Knopp MV; Giesel FL; Marcos H; von Tengg-Kobligk H; Choyke P
    Top Magn Reson Imaging; 2001 Aug; 12(4):301-8. PubMed ID: 11687716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic Contrast-Enhanced Magnetic Resonance Imaging as a Diagnostic Tool in the Assessment of Tumour Angiogenesis in Urinary Bladder Cancer.
    Hassanien OA; Abouelkheir RT; Abou El-Ghar MI; Badawy ME; El Gamal SA; El-Hamid MA
    Can Assoc Radiol J; 2019 Aug; 70(3):254-263. PubMed ID: 30922786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic contrast-enhanced magnetic resonance imaging for assessing tumor vascularity and vascular effects of targeted therapies in renal cell carcinoma.
    Rosen MA; Schnall MD
    Clin Cancer Res; 2007 Jan; 13(2 Pt 2):770s-776s. PubMed ID: 17255308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional tumor imaging with dynamic contrast-enhanced magnetic resonance imaging.
    Choyke PL; Dwyer AJ; Knopp MV
    J Magn Reson Imaging; 2003 May; 17(5):509-20. PubMed ID: 12720260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimized time-resolved imaging of contrast kinetics (TRICKS) in dynamic contrast-enhanced MRI after peptide receptor radionuclide therapy in small animal tumor models.
    Haeck J; Bol K; Bison S; van Tiel S; Koelewijn S; de Jong M; Veenland J; Bernsen M
    Contrast Media Mol Imaging; 2015; 10(6):413-20. PubMed ID: 25995102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The temporal correlation of dynamic contrast-enhanced magnetic resonance imaging with tumor angiogenesis in a murine glioblastoma model.
    Veeravagu A; Hou LC; Hsu AR; Cai W; Greve JM; Chen X; Tse V
    Neurol Res; 2008 Nov; 30(9):952-9. PubMed ID: 18662497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninvasive monitoring of therapy-induced microvascular changes in a pancreatic cancer model using dynamic contrast-enhanced magnetic resonance imaging with P846, a new low-diffusible gadolinium-based contrast agent.
    Casneuf VF; Delrue L; Van Damme N; Demetter P; Robert P; Corot C; Duyck P; Ceelen W; Boterberg T; Peeters M
    Radiat Res; 2011 Jan; 175(1):10-20. PubMed ID: 21175342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three-dimensional contrast enhanced ultrasound score and dynamic contrast-enhanced magnetic resonance imaging score in evaluating breast tumor angiogenesis: correlation with biological factors.
    Jia WR; Chai WM; Tang L; Wang Y; Fei XC; Han BS; Chen M
    Eur J Radiol; 2014 Jul; 83(7):1098-1105. PubMed ID: 24794865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early antiangiogenic activity of SU11248 evaluated in vivo by dynamic contrast-enhanced magnetic resonance imaging in an experimental model of colon carcinoma.
    Marzola P; Degrassi A; Calderan L; Farace P; Nicolato E; Crescimanno C; Sandri M; Giusti A; Pesenti E; Terron A; Sbarbati A; Osculati F
    Clin Cancer Res; 2005 Aug; 11(16):5827-32. PubMed ID: 16115922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional imaging of the angiogenic switch in a transgenic mouse model of human breast cancer by dynamic contrast enhanced magnetic resonance imaging.
    Consolino L; Longo DL; Dastrù W; Cutrin JC; Dettori D; Lanzardo S; Oliviero S; Cavallo F; Aime S
    Int J Cancer; 2016 Jul; 139(2):404-13. PubMed ID: 26941084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance macromolecular agents for monitoring tumor microvessels and angiogenesis inhibition.
    Preda A; van Vliet M; Krestin GP; Brasch RC; van Dijke CF
    Invest Radiol; 2006 Mar; 41(3):325-31. PubMed ID: 16481916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rectal cancer: dynamic contrast-enhanced MRI correlates with lymph node status and epidermal growth factor receptor expression.
    Lollert A; Junginger T; Schimanski CC; Biesterfeld S; Gockel I; Düber C; Oberholzer K
    J Magn Reson Imaging; 2014 Jun; 39(6):1436-42. PubMed ID: 24127411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining dynamic contrast enhanced magnetic resonance imaging and microvessel density to assess the angiogenesis after PEI in a rabbit VX2 liver tumor model.
    Chen J; Qian T; Zhang H; Wei C; Meng F; Yin H
    Magn Reson Imaging; 2016 Feb; 34(2):177-82. PubMed ID: 26518059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
    Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
    Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An EFSUMB introduction into Dynamic Contrast-Enhanced Ultrasound (DCE-US) for quantification of tumour perfusion.
    Dietrich CF; Averkiou MA; Correas JM; Lassau N; Leen E; Piscaglia F
    Ultraschall Med; 2012 Aug; 33(4):344-51. PubMed ID: 22843433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of dynamic contrast-enhanced MRI in cancer diagnosis and treatment.
    Türkbey B; Thomasson D; Pang Y; Bernardo M; Choyke PL
    Diagn Interv Radiol; 2010 Sep; 16(3):186-92. PubMed ID: 19885783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved diagnostic accuracy with multiparametric magnetic resonance imaging of the breast using dynamic contrast-enhanced magnetic resonance imaging, diffusion-weighted imaging, and 3-dimensional proton magnetic resonance spectroscopic imaging.
    Pinker K; Bogner W; Baltzer P; Gruber S; Bickel H; Brueck B; Trattnig S; Weber M; Dubsky P; Bago-Horvath Z; Bartsch R; Helbich TH
    Invest Radiol; 2014 Jun; 49(6):421-30. PubMed ID: 24566292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.